Gilead Sciences Inc, Ten Percent Owner at Achillion Pharmaceuticals, holds 1.12M shares in Achillion Pharmaceuticals (Ticker: ~ACHN), holds 7.35M shares in Xilio Therapeutics (Ticker: XLO), holds 4.13M shares in Kyverna Therapeutics, Inc. (Ticker: KYTX). Most recently, Gilead Sciences Inc ― shares of Achillion Pharmaceuticals on ― for an estimated value of ―.